Ravi Kumar Rajan | Ethnopharmacology | Young Scientist Award

Assist Prof Dr. Ravi Kumar Rajan | Ethnopharmacology | Young Scientist Award

👨‍🏫Profile Summary

As a pharmacy graduate, I am highly results-oriented and driven by objectives. My eagerness to learn new techniques and apply them effectively sets me apart. I excel at observing and troubleshooting problems, making me well-suited for careers in academia, pharmaceuticals, research and development (R&D), or clinical practice. With a strong foundation in pharmacy, I am ready to contribute meaningfully to any role I undertake and make a positive impact in the field.

🌐 Professional Profiles


🎓  Education

  • Ph.D. (Awarded on June 2022) in Pharmacy and Pharmaceutical Sciences from The Tamil Nadu Dr. MGR Medical University, Guindy, Chennai, Tamil Nadu.
  • Master of Pharmacy (2012-2014), specialized in Pharmacology & Toxicology, from PSG College of Pharmacy, Coimbatore, Tamil Nadu.
  • Bachelor of Pharmacy (2008-2012) from Swamy Vivekanandha College of Pharmacy, Elayampalayam, Tiruchengode, Tamil Nadu.

🔬Research Experience

  • Junior Research Fellowship under ‘DST- New Delhi’ focused on “Biogenic Synthesis of Silver Nanoconjugates with Natural Products for Breast Cancer” from December 2014 to December 2017.

🔍 Project

Ph.D. Project (2017-2020): Conducted Pre-clinical Evaluation of Neuroprotective Effects of Terpenes/Terpenoids and Stilbenoids in Ischemic Disease. Post-graduate Project (2013-2014): Evaluated soy isoflavones in letrozole-induced rat model of polycystic ovary syndrome. Undergraduate Project (2012-2013): Investigated the Effect of Hybanthus Enneaspermus in Streptozotocin-Nicotinamide Induced Type 2 Diabetes in Male Albino Rats.

🏆 Awards & Achievements

  • Secured Second Prize (2019) on the National level for Best Poster in the “7th PhD Poster Symposium on Chemistry and Biology Interface” jointly organized by the Royal Society of Chemistry (London) – Indian Deccan Local Section and National Institute of Pharmaceutical Education and Research (NIPER) Hyderabad.

📜  Certificates

“COVID-19 Contact Tracing” Course Certificate by COURSERA offered by JOHNS HOPKINS UNIVERSITY (June 2020). “Advanced Schrödinger Workshop” Hands-on training conducted at Schrödinger Office, Bangalore, focusing on Computer-Aided Drug Design (2020). “Computer-Aided Molecular Modeling and Dynamics” Hands-on training and workshop organized by the Department of Pharmacology, PSG College of Pharmacy, Coimbatore, Tamil Nadu (2019). “Molecular Modeling and Drug Discovery – Workshop IV” conducted by the Department of Pharmacology, PSG College of Pharmacy (2015). “Molecular Modeling and Drug Discovery – Workshop II” conducted by the Department of Pharmacology, PSG College of Pharmacy (2013).

📚Top Noted Publication

Title: Soy isoflavones exert beneficial effects on letrozole-induced rat polycystic ovary syndrome (PCOS) model through anti-androgenic mechanism

  • Authors: RK Rajan, B Balaji
  • Year: 2017


Title: Crystal structure, Hirshfeld surface analysis, DFT and molecular docking studies on benzohydrazide derivatives as potential inhibitors of prostate cancer

  • Authors: HA Arjun, RK Rajan, R Elancheran, M Ramanathan, A Bhattacharjee
  • Year: 2020


Title: Design, Synthesis, and Biological Evaluation of 2‐(2‐Bromo‐3‐nitrophenyl)‐5‐phenyl‐1, 3, 4‐oxadiazole Derivatives as Possible Anti‐Breast Cancer Agents

  • Authors: AH Ananth, N Manikandan, RK Rajan, R Elancheran, K Lakshmithendral
  • Year: 2020


Title: Synthesis and characterization of folic acid conjugated gemcitabine tethered silver nanoparticles (FA-GEM-AgNPs) for targeted delivery

  • Authors: A Karuppaiah, R Rajan, S Hariharan, DK Balasubramaniam, M Gregory
  • Year: 2020


Title: Building and Behavior of A pH-Stimuli Responsive Chitosan Nanoparticles Loaded with Folic Acid Conjugated Gemcitabine Silver Colloids In MDA-MB-453 Metastatic Breast Cancer

  • Authors: Arjunan Karuppaiah, Dinesh Babu, Divakar Selvaraj, Tamilselvan Natrajan
  • Year: 2021


Title: Cytotoxicity and synergistic effect of biogenically synthesized ternary therapeutic nano conjugates comprising plant active principle, silver and anticancer drug on MDA-MB-453

  • Authors: A Karuppaiah, R Rajan, M Ramanathan, A Nagarajan
  • Year: 2020


Title: Identification and neuroprotective evaluation of a potential c-Jun N-terminal kinase 3 inhibitor through structure-based virtual screening and in-vitro assay

  • Authors: RK Rajan, M Ramanathan
  • Year: 2020


Title: C–Glucosyl Xanthone derivative Mangiferin downregulates the JNK3 mediated caspase activation in Almal induced neurotoxicity in differentiated SHSY-5Y neuroblastoma cells

  • Authors: N Pk, RK Rajan, V Nanchappan, A Karuppaiah, J Chandrasekaran
  • Year: 2023


Title: In-silico and in-vitro analysis of novel substituted benzimidazolyl derivatives for antimycobacterial potentials targeting enoyl acyl carrier protein reductase (InhA)

  • Authors: U Kuppuswamy, RK Rajan, A Kumar, M Ramanathan
  • Year: 2022


Title: Piceatannol selectively inhibited the JNK3 enzyme and augmented apoptosis through inhibition of Bcl-2/Cyt-c/caspase-dependent pathways in the oxygen–glucose deprived SHSY-5Y

  • Authors: RKRM Ramanathan
  • Year: 2024


Title: Piceatannol improved cerebral blood flow and attenuated JNK3 and mitochondrial apoptotic pathway in a global ischemic model to produce neuroprotection

  • Authors: RK Rajan, RP Kumar, M Ramanathan
  • Year: 2024